COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB WITHOUT METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT

被引：0
|
作者：
Oksuz, E. [1 ]
Malhan, S. [1 ]
Yanik, L. [2 ]
Koc, E. [2 ]
Erdogan-Ciftci, E. [2 ]
Celik, H. [2 ]
Orfanos, P. [3 ]
机构：
[1] Baskent Univ, Ankara, Turkey
[2] Roche Mustahzarlari San AS, Istanbul, Turkey
[3] F Hoffmann La Roche, Basel, Switzerland
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.09.1770
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMS56
引用
收藏
页码：S297 / S297
页数：1
相关论文
共 50 条
  • [41] Leflunomid versus cyclosporin in methotrexate-resistant rheumatoid arthritis in Poland: A cost-effectiveness analysis
    Golicki, D.
    Niewada, M.
    Lis, J.
    Kaminski, B.
    Jakubczyk, M.
    Macioch, T.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A245 - A245
  • [42] Cost-effectiveness analysis of rituximab for rheumatoid arthritis in Taiwan
    Lou, S. F.
    Chen, D. Y.
    Cheng, T. T.
    Huang, C. M.
    Lin, H. Y.
    Su, C. C.
    Tsai, W. C.
    Tseng, J. C.
    Wei, C. C.
    Yang, L.
    Hazard, S.
    Chang, D. M.
    [J]. VALUE IN HEALTH, 2008, 11 (03) : A257 - A258
  • [43] COMBINATION DMARDS FOR RHEUMATOID ARTHRITIS: A COST-EFFECTIVENESS ANALYSIS
    Tosh, Jonathan
    Wailoo, Allan
    [J]. RHEUMATOLOGY, 2009, 48 : I68 - I69
  • [44] A cost-effectiveness analysis of biological treatments for rheumatoid arthritis
    Chiou, CF
    Wanke, L
    Yu, E
    Ofman, J
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 223 - 223
  • [45] Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain
    F. Navarro
    J. M. Martinez-Sesmero
    A. Balsa
    C. Peral
    M. Montoro
    M. Valderrama
    S. Gómez
    F. de Andrés-Nogales
    M. A. Casado
    Itziar Oyagüez
    [J]. Clinical Rheumatology, 2020, 39 : 2919 - 2930
  • [46] Cost-effectiveness analysis of treatment sequences containing tofacitinib for the treatment of rheumatoid arthritis in Spain
    Navarro, F.
    Martinez-Sesmero, J. M.
    Balsa, A.
    Peral, C.
    Montoro, M.
    Valderrama, M.
    Gomez, S.
    De Andres-Nogales, F.
    Casado, M. A.
    Oyaguez, Itziar
    [J]. CLINICAL RHEUMATOLOGY, 2020, 39 (10) : 2919 - 2930
  • [47] THE COMPARATIVE EFFECTIVENESS OF ORAL METHOTREXATE VERSUS SUBCUTANEOUS METHOTREXATE FOR THE INITIAL TREATMENT OF EARLY RHEUMATOID ARTHRITIS
    Hazlewood, G.
    Thorne, C.
    Pope, J.
    Boire, G.
    Haraoui, B.
    Hitchon, C.
    Keystone, E.
    Tin, D.
    Bykerk, V.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 246 - 246
  • [48] Subcutaneous tocilizumab: recent advances for the treatment of rheumatoid arthritis
    Ogata, Atsushi
    Kato, Yasuhiro
    Higa, Shinji
    Maeda, Keiji
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2019, 16 (06) : 639 - 648
  • [49] The comparative effectiveness of oral versus subcutaneous methotrexate for the treatment of early rheumatoid arthritis
    Hazlewood, Glen S.
    Thorne, J. Carter
    Pope, Janet E.
    Lin, Daming
    Tin, Diane
    Boire, Gilles
    Haraoui, Boulos
    Hitchon, Carol A.
    Keystone, Edward C.
    Jamal, Shahin
    Bykerk, Vivian P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (06) : 1003 - 1008
  • [50] COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN INSTITUTIONAL MARKET IN ECUADOR
    Albuja, M. F.
    Torres, F. G.
    Mould, J.
    Estevez, C.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A717 - A717
12345